Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1650-1657

  Wagner, R S ^a   Smith, C J ^a,b   Taylor, A M ^a   Rhoades, R A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 BROMO CYCLIC AMP; BUCLADESINE; CILOMILAST; FORSKOLIN; ISOPRENALINE; MILRINONE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; POTASSIUM CHLORIDE; ROLIPRAM; UNCLASSIFIED DRUG;

AGONIST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASCULAR RING;

ANIMALS; ANOXIA; BUCLADESINE; HYPERTENSION, PULMONARY; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION; VASODILATION;

EID: 0030988865     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ADNOT, S., RAFFESTIN, B., EDDAHIBI, S., BRAQUET, P. AND CHABRIER, P. E.: Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87: 155-162, 1991.
2. ALPERT, M. A., CONCANNON, M. D., MUKERJI, B. AND MUKERJI, V.: Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part II: Secondary pulmonary hypertension [Review]. Angiology 45: 755-761, 1994.
3. AMERICAN THORACIC SOCIETY BOARD OF DIRECTORS: Future directions for research on diseases of the lung. Am. J. Respir. Crit. Care Med. 152: 1713-1735, 1995.
4. BADESCH, D. B., ORTON, E. C., ZAPP, L. M., WESTCOTT, J. Y., HESTER. J., VOELKEL, N. F. AND STENMARK, K. R.: Decreased arterial wall prostaglandin product in neonatal calves with severe chronic pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 1: 489-498, 1989.
5. BEAVO, J. A.: Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol. Rev. 75: 725-748, 1995.
6. CONTI, M., NEMOZ, G., SETTE, C. AND VICINI, E.: Recent progress in understanding the hormonal regulation of phosphodiesterases [Review]. Endocr. Rev. 16: 370-389, 1995.
7. CRAWLEY, D. E., ZHAO, L., GIEMBYCZ, M. A., LIU, S., BARNES, P. J., WINTER, R. J. AND EVANS, T. W.: Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am. J. Physiol. 263: L325-L332, 1992.
8. CREMONA, G. AND HIGENBOTTAM, T.: Role of prostacyclin in the treatment of primary pulmonary hypertension [Review]. Am. J. Cardiol. 75: 67A-71A, 1995.
9. DENT, G., MAGNUSSEN, H. AND RABE, K. F.: Cyclic nucleotide phosphodiesterases in the human lung [Review]. Lung 172: 129-146, 1994.
10. 2 stimulated signal transduction in vascular smooth muscle. J. Pharmacol. Exp. Ther. 265: 447-456, 1992.
11. GOLAN, A., ZALZSTEIN, E., ZMORA, E. AND SHINWELL, E. S.: Pulmonary hypertension in respiratory distress syndrome. Pediatr. Pulmonol. 19: 221-225, 1995.
12. GRIFFITH, S. L., RHOADES, R. A. AND PACKER, C. S.: Pulmonary arterial smooth muscle contractility in hypoxia-induced pulmonary hypertension. J. Appl. Physiol. 77: 406-414, 1994.
13. HAYNES, J., ROBINSON, J., SAUNDERS, L., TAYLOR, A. E. AND STRADA, S. J.: Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation. Am. J. Physiol. 262: H511-H516, 1992.
14. HIGENBOTHAM, T. AND CREMONA, G.: Acute and chronic hypoxic pulmonary hypertension [Review]. Eur. Respir. J. 6: 1207-1212, 1993.
15. JOHNSTON, E., SWEENEY, G., MCCULLOCH, K., BAIRD, M., POOLEY, L., HOUSLAY, M. D. AND MACLEAN, M.: Modulation of cyclic nucleotide metabolism by phosphodiesterasae isoforms in pulmonary hypertension [Abstract]. Third International Conference on Cyclic Nucleotide Phosphodiesterasaes: From Genes to Therapies, Glasgow, Scotland, A133, 1996.
16. KAUFFMAN, R. F., SCHENCK, K. W., UTTERBACK, B. G., CROWE, V. G. AND COHEN, M. L.: In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J. Pharmacol. Exp. Ther. 242: 864-872, 1987.
17. KINSELLA, J. P. AND ABMAN, S. H.: Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn [Review]. J. Pediatr. 126: 853-864, 1995.
18. KOMAS, N., LUGNIER, C. AND STOCLET, J.: Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br. J. Pharmacol. 104: 495-503, 1991.
19. 2+ by cAMP in vascular smooth muscle. Am. J. Physiol. 258: C399-C407, 1990.
20. LUGNIER, C. AND KOMAS, N.: Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Eur. Heart J. 14: 141-148, 1993.
21. LUNN, R. J.: Inhaled nitric oxide therapy [Review]. Mayo Clin. Proc. 70: 247-255, 1995.
22. MACDONALD, K. L. AND DIAMOND, J.: Activation of cAMP-dependent protein kinase in rat aorta by cAMP analogs is not correlated with relaxation. J. Vasc. Res. 31: 121-130, 1994.
23. PAN, X., ARAUZ, E., KRZANOWSKI, J. J., FITZPATRICK, D. F. AND POLSON, J. B.: Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells. Biochem. Pharmacol. 48: 827-835, 1994.
24. PINSKY, D., OZ, M., LIAO, H., MORRIS, S., BRETT, J., SCIACCA, R., KARAKURUM, M., VAN LOOKEREN CAMPAGNE, M., PLATT J. AND NOWYGROD R.: Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotrophic rat model. J. Clin. Invest. 92: 2994-3002, 1993.
25. POLSON, J. B. AND STRADA, S. J.: Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Chronic hypoxic pulmonary hypertension. Cell biology to pathophysiology [Review]. Annu. Rev. Pharmacol. Toxicol. 36: 403-427, 1996.
26. RABE, K. F., TENOR, H., DENT, G., SCHUDT, C., NAKASHIMA, M. AND MAGNUSSEN, H.: Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am. J. Physiol. 266: L536-L543, 1994.
27. SHAUL, P. W., KINANE, B., FARRAR, M. A., BUJA, L. M. AND MAGNESS, R. R.: Prostacyclin production and mediation of adenylate cyclase activity in the pulmonary artery. Alterations after prolonged hypoxia in the rat. J. Clin. Invest. 88: 447-455, 1991.
28. SHAUL, P. W., MUNTZ, K. H., DEBELTZ, D. AND BUJA, L. M.: Effects of prolonged hypoxia on adenylate cyclase activity and beta-adrenergic receptors in pulmonary and systemic arteries of the rat. Circ. Res. 66: 1526-1534, 1990.
29. SHAUL, P. W., NORTH, A. J., BRANNON, T. S., UJIIE, K., WELLS, L. B., NISEN, P. A., LOWENSTEIN, C. J., SNYDER, S. H. AND STAR, R. A.: Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am. J. Respir. Cell Mol. Biol. 13: 167-174, 1995.
30. SMITH, C. J., HAIDER, S. R., DING, J., BENTLEY-HIBBERT, S., MOGGIO, R. A. AND STEMERMAN, M. B.: Selective regulation of smooth muscle cyclic AMP phosphodiesterases by vascular injury and cyclic AMP [Abstract]. 9th International Conference on Second Messengers and Phosphoproteins, Nashville, TN. 65, 1995.
31. SU, Y. AND BLOCK, E. R.: Hypoxia inhibits L-arginine synthesis from L-citrulline in porcine pulmonary artery endothelial cells. Am. J. Physiol. 269: L581-L587, 1995.
32. TAIRA, M., HOCKMAN, S. C., CALVO, J. C., BELFRAGE,. AND MANGANIELLO, V. C.: Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem. 268: 18573-18579, 1993.
33. VENDER, R. L.: Chronic hypoxic pulmonary hypertension. Cell biology to pathophysiology. Chest 106: 236-243, 1994.
34. WANSTALL, J. C. AND O'DONNELL, S. R.: Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br. J. Pharmacol. 105: 152-158, 1992.